BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12642504)

  • 1. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure.
    Kacimi R; Gerdes AM
    Hypertension; 2003 Apr; 41(4):968-77. PubMed ID: 12642504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
    Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
    J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
    Satoh M; Matter CM; Ogita H; Takeshita K; Wang CY; Dorn GW; Liao JK
    Circulation; 2007 Jun; 115(25):3197-204. PubMed ID: 17562954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure.
    Satoh S; Ueda Y; Koyanagi M; Kadokami T; Sugano M; Yoshikawa Y; Makino N
    J Mol Cell Cardiol; 2003 Jan; 35(1):59-70. PubMed ID: 12623300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase.
    Liu D; Gao L; Roy SK; Cornish KG; Zucker IH
    Circ Res; 2006 Oct; 99(9):1004-11. PubMed ID: 17008603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model.
    Ye Y; Gong G; Ochiai K; Liu J; Zhang J
    Circulation; 2001 Mar; 103(11):1570-6. PubMed ID: 11257087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
    Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
    Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq.
    Minamino T; Yujiri T; Terada N; Taffet GE; Michael LH; Johnson GL; Schneider MD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3866-71. PubMed ID: 11891332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
    Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
    Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy.
    Kagiyama S; Qian K; Kagiyama T; Phillips MI
    Hypertension; 2003 Mar; 41(3 Pt 2):824-9. PubMed ID: 12624003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats.
    Kishi T; Hirooka Y; Konno S; Ogawa K; Sunagawa K
    Hypertension; 2010 Feb; 55(2):291-7. PubMed ID: 20065158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMUP-1 inhibits hypertension-induced left ventricular hypertrophy through regulation of nitric oxide synthases, ERK1/2, and calcineurin.
    Yeh JL; Liu CP; Hsu JH; Tseng CJ; Wu PJ; Wang YY; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2012 Nov; 28(11):567-76. PubMed ID: 23140764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.
    Liang Q; Elson AC; Gerdes AM
    J Card Fail; 2006 Aug; 12(6):479-86. PubMed ID: 16911916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.